vs
Side-by-side financial comparison of NorthEast Community Bancorp, Inc. (NECB) and Neuphoria Therapeutics Inc. (NEUP). Click either name above to swap in a different company.
NorthEast Community Bancorp, Inc. is the larger business by last-quarter revenue ($26.4M vs $15.0M, roughly 1.8× Neuphoria Therapeutics Inc.). Neuphoria Therapeutics Inc. runs the higher net margin — 75.1% vs 40.9%, a 34.2% gap on every dollar of revenue.
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
Neuphoria Therapeutics Inc is a clinical-stage biopharmaceutical company focused on researching and developing innovative targeted therapies for unmet medical needs in neurological and psychiatric conditions, including anxiety, treatment-resistant depression, and other central nervous system disorders. Its core R&D efforts prioritize delivering safer, more effective treatment options for patient groups with limited existing care alternatives.
NECB vs NEUP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.4M | $15.0M |
| Net Profit | $10.8M | $11.3M |
| Gross Margin | — | — |
| Operating Margin | 59.0% | 79.8% |
| Net Margin | 40.9% | 75.1% |
| Revenue YoY | 3.9% | — |
| Net Profit YoY | 5.8% | — |
| EPS (diluted) | $0.78 | $6.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.4M | — | ||
| Q3 25 | $27.0M | — | ||
| Q2 25 | $25.9M | — | ||
| Q1 25 | $25.5M | $15.0M | ||
| Q4 24 | $25.4M | — | ||
| Q3 24 | $27.6M | — | ||
| Q2 24 | $27.0M | — | ||
| Q1 24 | $25.5M | — |
| Q4 25 | $10.8M | — | ||
| Q3 25 | $11.9M | — | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $10.6M | $11.3M | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | $12.7M | — | ||
| Q2 24 | $12.8M | — | ||
| Q1 24 | $11.4M | — |
| Q4 25 | 59.0% | — | ||
| Q3 25 | 61.6% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 57.4% | 79.8% | ||
| Q4 24 | 57.0% | — | ||
| Q3 24 | 63.6% | — | ||
| Q2 24 | 65.6% | — | ||
| Q1 24 | 62.7% | — |
| Q4 25 | 40.9% | — | ||
| Q3 25 | 44.0% | — | ||
| Q2 25 | 43.1% | — | ||
| Q1 25 | 41.4% | 75.1% | ||
| Q4 24 | 40.1% | — | ||
| Q3 24 | 45.9% | — | ||
| Q2 24 | 47.5% | — | ||
| Q1 24 | 44.5% | — |
| Q4 25 | $0.78 | — | ||
| Q3 25 | $0.87 | — | ||
| Q2 25 | $0.82 | — | ||
| Q1 25 | $0.78 | $6.55 | ||
| Q4 24 | $0.74 | — | ||
| Q3 24 | $0.95 | — | ||
| Q2 24 | $0.97 | — | ||
| Q1 24 | $0.86 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $81.2M | $17.0M |
| Total DebtLower is stronger | $70.0M | — |
| Stockholders' EquityBook value | $351.7M | $26.0M |
| Total Assets | $2.1B | $30.7M |
| Debt / EquityLower = less leverage | 0.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.2M | — | ||
| Q3 25 | $64.3M | — | ||
| Q2 25 | $59.4M | — | ||
| Q1 25 | $89.5M | $17.0M | ||
| Q4 24 | $78.3M | — | ||
| Q3 24 | $97.8M | — | ||
| Q2 24 | $113.9M | — | ||
| Q1 24 | $107.4M | — |
| Q4 25 | $70.0M | — | ||
| Q3 25 | $170.0M | — | ||
| Q2 25 | $135.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $7.0M | — | ||
| Q2 24 | $47.0M | — | ||
| Q1 24 | $47.0M | — |
| Q4 25 | $351.7M | — | ||
| Q3 25 | $344.0M | — | ||
| Q2 25 | $336.7M | — | ||
| Q1 25 | $327.2M | $26.0M | ||
| Q4 24 | $318.3M | — | ||
| Q3 24 | $309.6M | — | ||
| Q2 24 | $300.0M | — | ||
| Q1 24 | $288.9M | — |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | $30.7M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.6M | $11.5M |
| Free Cash FlowOCF − Capex | $50.8M | — |
| FCF MarginFCF / Revenue | 192.3% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | 4.86× | 1.02× |
| TTM Free Cash FlowTrailing 4 quarters | $89.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.6M | — | ||
| Q3 25 | $14.1M | — | ||
| Q2 25 | $15.6M | — | ||
| Q1 25 | $10.9M | $11.5M | ||
| Q4 24 | $48.7M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $11.1M | — | ||
| Q1 24 | $12.9M | — |
| Q4 25 | $50.8M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $48.2M | — | ||
| Q3 24 | $14.2M | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | $12.8M | — |
| Q4 25 | 192.3% | — | ||
| Q3 25 | 50.5% | — | ||
| Q2 25 | 57.3% | — | ||
| Q1 25 | 41.4% | — | ||
| Q4 24 | 189.3% | — | ||
| Q3 24 | 51.5% | — | ||
| Q2 24 | 40.8% | — | ||
| Q1 24 | 50.3% | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 4.86× | — | ||
| Q3 25 | 1.18× | — | ||
| Q2 25 | 1.40× | — | ||
| Q1 25 | 1.04× | 1.02× | ||
| Q4 24 | 4.77× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 1.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
